Our 2021 Joint Mandate Letter

Mandate Letter Signatories

Dr. Jason Field, President and CEO, Life Sciences Ontario, Co-Chair, Resilient Healthcare Coalition

Eva Villalba, Executive Director, Coalition Priorité Cancer au Québec, Co-Chair, Resilient Healthcare Coalition

Brian Heath, Vice President & General Manager, Amgen Canada, RHC Member

Sian Bevan, Chief Science Officer, The Arthritis Society, RHC Member

Kiersten Combs, President, AstraZeneca Canada, RHC Member

Connie Cote, Chief Executive Officer, Health Charities Coalition of Canada, RHC Member

Barry Stein, President and CEO, Colorectal Cancer Canada, RHC Member

Paul-Emile Cloutier, President and CEO, HealthCareCAN, RHC Member

Peter Glazier, Executive Vice President, Lung Health Foundation, RHC Member

Nicole DeKort, Vice-President, Ontario & Marketing, MedTech Canada, RHC Member

Louise Binder, Health Policy Consultant, Save Your Skin Foundation, RHC Member

Ronald Miller, President & CEO, Roche Canada, RHC Member

Gerard Yetman, Chair, Action Hepatitis Canada

Leah Stephenson, Strategic Lead, All.Can Canada

Kim Kline, President, Bioscience Association of Manitoba

John Adams, Chair, Board of Directors, Best Medicines Coalition

Robb Stoddard, President and CEO, BioAlberta

Stephanie Michaud, President and CEO, BioCanRx

Meaghan Seagrave, Executive Director, BioNB

Scott Moffitt, Executive Director, BioNova

Anie Perrault, Directrice general, BioQuébec

Gerry Wright, Lead, Canada’s Global Nexus for Pandemics and Biological Threats, McMaster University

Jodi Hall, CEO, Canadian Association of Long-Term Care

Rachael Manion, Executive Director, Canadian Association of Psoriasis Patients

Cathy Ammendolea, Chair, Canadian Breast Cancer Network

Honourable Perrin Beatty, P.C., O.C., President and CEO, Canadian Chamber of Commerce

Durhane Wong-Reiger, President and CEO, Canadian Organization for Rare Disorders

Rachael Manion, Executive Director, Canadian Skin Patient Alliance

Wendy Gerhart, Executive Director, Canadian Association of Psoriasis Patients, Canadian Spondylitis Association

Susan Marlin, President and CEO, Clinical Trials Ontario

Charles Milliard, Président-directeur general, Féderation des chambres de commerce du Quebec

Dawn Bowdish, Executive Director, Firestone Institute of Respiratory Health, St. Joseph’s Healthcare

Gail Attara, President and CEO, Gastrointestinal Society

Daniel Coderre, Ph.D., ASC Président-dicecteur general Génome Québec

David Josephy, President, GIST Sarcoma Life Raft Group Canada

Teresa Norris, Founder and President, HPV Global Action

Pamela Fralick, President, Innovative Medicines Canada

David Prowten, President and CEO, Juvenile Diabetes Research Foundation

John-Peter Bradford, Co-Founder and CEO, Life Saving Therapy Network

Wendy Hurlburt, President and CEO, Life Sciences BC

Leanne Mielczarek, Executive Director, Lupus Canada

Antonella Rizza, CEO, Lymphoma Canada

Frank Beraud, Président-direceur general, Montreal Invivo

Martine Elias, Executive Director, Myeloma Canada

Sandra Hanna, Chief Executive Officer, Neighbourhood Pharmacy Association of Canada

Jennifer van Gennip, Executive Director, Network of Rare Blood Disorder Organizations

Michelle Capobianco, CEO, Pancreatic Cancer Canada

Zal Press, Executive Director, Patient Commando Productions

Rory Francis, CEO, Prince Edward Island BioAlliance

Lucie D’Armours, Directrice générale, Quebec-Clinical Research in Oncology

MJ Decoteau, Founder and Executive Director, Rethink Breast Cancer

Jade Dagher, Head of Sub-Region Canada, Australia and New Zealand, Roche Diabetes Care

Bradly G. Wouters, Ph.D., Executive Vice President, Science & Research, University Health Network

Keith Ethier, Directeur général, Medsup Canada

A letter from the Resilient Healthcare Coalition to the Prime Minister of Canada on October 28, 2021. If you are interested in joining the growing list of supporters, please email info@resilienthealthcare.ca.

Dear Prime Minister Trudeau,

We are writing to you today as allies and members of the Resilient Healthcare Coalition (RHC), a collaborative of health system partners committed to providing the leadership, insights, and solutions required to make Canadian health systems stronger and more resilient.

The RHC brings together a diverse group of health system leaders from industry, research, and advocacy groups across the public, private, and non-profit sectors. Our mission is to create Canadian health care systems that improve patient care and health outcomes by evolving to become faster, nimbler, and better able to absorb future shocks.

COVID-19 has supercharged a global policy discussion around health system resilience that has direct and immediate relevance to Canada. To increase the resilience of Canadian health systems, the RHC is committed to working with a wide range of allies and advocates to accomplish two fundamental goals. First, optimizing the use of healthcare data to develop and deploy more coordinated, integrated, and effective virtual care. Second, expanding and accelerating access to innovative health technologies – from vaccines and diagnostics to therapeutics and medical devices.

As you convene your cabinet and articulate your new mandate, the RHC has drafted a hypothetical Joint Mandate Letter that captures the kind of bold, compelling and essential policy recommendations that can only be accomplished through the collaborative efforts of your new Ministers of Health and Innovation, Science and Industry.

We are confident that its recommendations will provide you with the foundational ideas your government needs to help healthcare systems across Canada build back even better than they were before the pandemic.

The RHC would appreciate the opportunity to meet with officials from the your office to not only expand on our recommendations, but also explore how the Coalition could best share the ideas, insights and advice of the broader healthcare and life sciences ecosystem.